✦ LIBER ✦

Practical Considerations for the Pharmacokinetic and Immunogenic Assessment of Antibody–Drug Conjugates

✍ Scribed by Sauerborn, Melody; van Dongen, William

Book ID: 125386740
Publisher: Springer International Publishing AG
Year: 2014
Tongue: English
Weight: 973 KB
Volume: 28
Category: Article
ISSN: 1173-8804
DOI: 10.1007/s40259-014-0096-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical and clinical pharmacokinetic

Preclinical and clinical pharmacokinetic/pharmacodynamic considerations for antibody–drug conjugates

✍ Sapra, Puja; Betts, Alison; Boni, Joseph 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 517 KB

Considerations for the nonclinical safet

Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology

✍ Roberts, Stanley A.; Andrews, Paul A.; Blanset, Diann; Flagella, Kelly M.; Gorov 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Absorption, Distribution, Metabolism, an

Absorption, Distribution, Metabolism, and Excretion Considerations for the Development of Antibody-Drug Conjugates

✍ Han, T. H.; Zhao, B. 📂 Article 📅 2014 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 176 KB

Antibody-Drug Conjugates and Immunotoxin

Antibody-Drug Conjugates and Immunotoxins || Antibody–Drug Conjugates for the Treatment of B-Cell Malignancies

✍ Phillips, Gail Lewis 📂 Article 📅 2012 🏛 Springer New York 🌐 English ⚖ 267 KB

This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

Development of Antibody-Based Therapeuti

Development of Antibody-Based Therapeutics || Bioanalytical Considerations for Development of Antibody-Based Therapeutics: Pharmacokinetics and Immunogenicity

✍ Tabrizi, Mohammad A.; Bornstein, Gadi G.; Klakamp, Scott L. 📂 Article 📅 2012 🏛 Springer New York ⚖ 515 KB

Monoclonal antibodies: what are the phar

Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?

✍ Deng, Rong; Jin, Feng; Prabhu, Saileta; Iyer, Suhasini 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 514 KB